Finch Therapeutics Group Inc
FNCH
Market Cap$3.6M
Close$
Share Statistics
| Market cap | $3.60 Million |
|---|---|
| Enterprise Value | $8.60 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-46.59 |
| Beta | 0.0 |
| Outstanding Shares | 1,605,763 |
| Avg 30 Day Volume | 98,749 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.05 |
|---|---|
| PEG | 0.05 |
| Price to Sales | - |
| Price to Book Ratio | 0.17 |
| Enterprise Value to Revenue | 80.36 |
| Enterprise Value to EBIT | -0.25 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 3.5 |
| Debt to Equity | 1.32 |
Revenue Sources
No data
ESG Score
No data
About Finch Therapeutics Group Inc
131 employeesFinch Therapeutics is a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs. With the capabilities to develop both complete and ta...